IRLAB THERAP. AB A

IRLAB THERAP. AB A

Share · SE0012675361 · A2PLBE (XSTO)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of IRLAB THERAP. AB A
No Price
Closing Price XSTO 29.04.2026: 1,42 SEK
29.04.2026 15:20
Current Prices from IRLAB THERAP. AB A
ExchangeTickerCurrencyLast TradePriceDaily Change
XSTO: NASDAQ STOCKHOLM AB
NASDAQ STOCKHOLM AB
IRLAB-A.ST
SEK
29.04.2026 15:20
1,42 SEK
-0,07 SEK
-4,57 %
Share Float & Liquidity
Free Float 79,54 %
Shares Float 67,5 M
Shares Outstanding 84,86 M
Company Profile for IRLAB THERAP. AB A Share
IRLAB Therapeutics AB (publ) develops drugs for the treatment of Parkinson's disease. The company develops Mesdopetam that is in phase IIb/III clinical studies for the treatment of dyskinesia; and Pirepemat, which is in phase IIb clinical trial for the treatment of Postural dysfunction. Its preclinical stage products include IRL942 and 1009 research programs for the treatment of neurodegenerative disorders and ageing; and IRL757 to treat apathy in neurological diseases. In addition, the company develops P003, a research project that develops drugs for the treatment of newly diagnosed Parkinson's disease. IRLAB Therapeutics AB (publ) was incorporated in 2013 and is based in Gothenburg, Sweden.

Company Data

Name IRLAB THERAP. AB A
Company IRLAB Therapeutics AB (publ)
Website https://www.irlab.se
Primary Exchange XSTO NASDAQ STOCKHOLM AB
WKN A2PLBE
ISIN SE0012675361
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Kristina Torfgard
Market Capitalization 126 Mio
Country Sweden
Currency SEK
Employees 0,0 T
Address Arvid Wallgrens Backe 20, 413 46 Gothenburg
IPO Date 2017-02-28

Stock Splits

Date Split
06.02.2020 1017:1000
28.05.2019 5:1

Ticker Symbols

Name Symbol
NASDAQ STOCKHOLM AB IRLAB-A.ST
Frankfurt 6IRA.F
More Shares
Investors who hold IRLAB THERAP. AB A also have the following shares in their portfolio:
DZ HYP AG MTN-Hyp.Pfbr.389 18(38) [WL]
DZ HYP AG MTN-Hyp.Pfbr.389 18(38) [WL] Unbekannt
SUMITOMO MITSUI F. 16/26
SUMITOMO MITSUI F. 16/26 Bond